UBS AM
VMD icon

UBS AM’s Viemed Healthcare VMD Stock Holding History

UBS AM’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.1K Hold
4,305
– – ﹤0.01% 2935
2026
Q1 		$39.6K Buy
4,305
+3,890
+937% +$32.4K ﹤0.01% 3001
2025
Q4 		$3.08K Buy
+415
New +$2.84K ﹤0.01% 3069
2021
Q2 		– Sell
-57,100
Closed -$581K – 2780
2021
Q1 		$581K Hold
57,100
– – ﹤0.01% 2334
2020
Q4 		$446K Buy
57,100
+22,500
+65% +$198K ﹤0.01% 2327
2020
Q3 		$299K Buy
34,600
+7,300
+27% +$73.6K ﹤0.01% 2301
2020
Q2 		$261K Buy
+27,300
New +$212K ﹤0.01% 2322

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS AM's VMD Position: Q2 2026 in Review

UBS AM held its Viemed Healthcare (VMD) position steady in Q2 2026 at 4,305 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

UBS AM first reported a position in VMD in Q2 2020 and has held it in 7 quarters since. The position peaked at $581K in Q1 2021. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • UBS AM held 4,305 shares of Viemed Healthcare worth $49.1K as of Q2 2026.
  • UBS AM left its Viemed Healthcare share count unchanged in Q2 2026.
  • Viemed Healthcare made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2935 holding.
  • UBS AM first reported a position in Viemed Healthcare in Q2 2020 and has held it in 7 quarters since.
  • UBS AM's Viemed Healthcare position peaked at $581K in Q1 2021.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.